PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset
Presentation Product Chemical substance Chapter Items dispensed
Interferon alfa-2b 18million units/1.2ml inj pf dispos dev
0802040J0AABBBB
Interferon A Interferon alpha Malignant Disease and Immunosuppression No data available
Interferon alfa-2b 18million units/3ml inj vials
0802040J0AAAUAU
Interferon A Interferon alpha Malignant Disease and Immunosuppression No data available
Interferon alfa-2b 1million unit inj vials
0802040J0AAAKAK
Interferon A Interferon alpha Malignant Disease and Immunosuppression No data available
Interferon alfa-2b 25million units/2.5ml inj multidose vials
0802040J0AABEBE
Interferon A Interferon alpha Malignant Disease and Immunosuppression No data available
Interferon alfa-2b 30million units/1.2ml inj pf dispos dev
0802040J0AABCBC
Interferon A Interferon alpha Malignant Disease and Immunosuppression No data available
Interferon alfa-2b 3million unit inj vials
0802040J0AAAGAG
Interferon A Interferon alpha Malignant Disease and Immunosuppression No data available
Interferon alfa-2b 60million units/1.2ml inj pf dispos dev
0802040J0AABDBD
Interferon A Interferon alpha Malignant Disease and Immunosuppression No data available
Interferon beta-1a 12 million units/0.5ml inj 1.5ml cart
0802040M0AAAKAK
Interferon B Interferon beta Malignant Disease and Immunosuppression No data available
Interferon beta-1a 12million units/0.5ml inj pf dispos dev
0802040M0AAANAN
Interferon B Interferon beta Malignant Disease and Immunosuppression No data available
Interferon beta-1a 12million units/0.5ml inj pfs
0802040M0AAAGAG
Interferon B Interferon beta Malignant Disease and Immunosuppression No data available
Interferon beta-1a 30microgram inj vials
0802040M0AAAEAE
Interferon B Interferon beta Malignant Disease and Immunosuppression No data available
Interferon beta-1a 6million units/0.5ml inj 1.5ml cartridges
0802040M0AAAJAJ
Interferon B Interferon beta Malignant Disease and Immunosuppression No data available
Interferon beta-1a 6million units/0.5ml inj pf dispos dev
0802040M0AAAMAM
Interferon B Interferon beta Malignant Disease and Immunosuppression No data available
Interferon beta-1a 6million units/0.5ml inj pfs
0802040M0AAAFAF
Interferon B Interferon beta Malignant Disease and Immunosuppression No data available
Interferon beta-1a 6mu/0.5ml & 2.4mu/0.2ml inj pf dev
0802040M0AAAQAQ
Interferon B Interferon beta Malignant Disease and Immunosuppression No data available
Interferon beta-1a 6mu/0.5ml & 2.4mu/0.2ml inj pfs
0802040M0AAAIAI
Interferon B Interferon beta Malignant Disease and Immunosuppression No data available
Interferon beta-1b 300microgram inj vials
0802040M0AAADAD
Interferon B Interferon beta Malignant Disease and Immunosuppression No data available
Interferon gamma-1b (rcmb human) 100microg/0.5ml inj vials
0802040Z0AAAAAA
Interferon gamma-1b Interferon gamma Malignant Disease and Immunosuppression No data available
Interglide coated catheter paediatric 8Ch-10Ch
21020000842
Interglide coated catheter paediatric 8Ch-10Ch Catheters Appliances No data available
Interpose dressing 10cm x 10cm
20030100271
Interpose dressing 10cm x 10cm Wound Management & Other Dressings Dressings No data available
Interpose dressing 20cm x 10cm
20030100272
Interpose dressing 20cm x 10cm Wound Management & Other Dressings Dressings No data available
Interpose dressing 5cm x 5cm
20030100270
Interpose dressing 5cm x 5cm Wound Management & Other Dressings Dressings No data available
Intersurgical 005 mask
21080001014
Intersurgical 005 mask Oxygen Masks Appliances No data available
Intersurgical 010 28% mask
21080001015
Intersurgical 010 28% mask Oxygen Masks Appliances No data available
InterVax BCG vacc inj ampoules
1404000C0BCAAAF
InterVax BCG Bacillus calmette-guerin (B.C.G.) Immunological Products and Vaccines No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.